Summary of Study ST002208
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001410. The data can be accessed directly via it's Project DOI: 10.21228/M8G42C This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST002208 |
Study Title | Metabolomic analysis to assess response to immunotherapy for malignant brain tumors: Part 2 |
Study Type | Cancer surrogate biomarker discovery |
Study Summary | An effective immune response in patients with cancer treated with immunotherapy includes dendritic cell (DC) activation and migration followed by stimulation of CD8 and CD4 T cells. This then leads to the activation, proliferation and further activation of other immune cell populations including NK cells or immunosuppressive populations such as Tregs and myeloid derived suppressor cells (MDSCs). These studies were carried out utilizing murine brain tumor models treated with an RNA DC vaccine platform. We hypothesized that metabolomic analyses of urines would be sensitive to the action of this diverse set of immune cells. The objective of this study was to evaluate the feasibility of using metabolomics to follow immune responses after immunotherapy. We chose NMR as our analytical technique of choice, as it has many favorable qualities that make it ideal for analyses of urine. |
Institute | University of Florida |
Department | Applied Physiology and Kinesiology |
Laboratory | Rm 042 |
Last Name | Khattri |
First Name | Ram |
Address | 1200 Newell Dr., ARB 240, Gainesville, FL, 32611, USA |
rbk11@ufl.edu | |
Phone | 3307856045 |
Submit Date | 2022-06-09 |
Num Groups | 10 |
Total Subjects | 80 |
Num Males | NA |
Num Females | NA |
Study Comments | Metabolomic profiling of urine samples |
Publications | Metabolomics journal (submitted) |
Raw Data Available | Yes |
Raw Data File Type(s) | fid |
Analysis Type Detail | NMR |
Release Date | 2023-06-16 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Sample Preparation:
Sampleprep ID: | SP002300 |
Sampleprep Summary: | No filtration was performed for urine samples. The urine samples were centrifuged at 4 oC, with 13.2 K rpm speed before mixing it with an internal reference and phosphate buffer system. |
Sampleprep Protocol Filename: | DC_Vaccine_treated_NMR_urine_Procedures.docx |
Processing Method: | None |
Processing Storage Conditions: | -80℃ |
Extraction Method: | None |
Extract Storage: | -80℃ |
Sample Resuspension: | In 500 microliter of 150 mM phosphate buffer (pH 7.2) with 2 mM EDTA, 0.5 mM DSS and 0.2% sodium azide for aqueous phase samples. |
Sample Spiking: | 0.5 mM DSS for urine samples |